ANDA 75166, held by Skyepharma AG. Isosorbide Mononitrate.
As of Nov 16, 2026, ANDA 75166 (Isosorbide Mononitrate), held by Skyepharma AG, was first approved by FDA on Oct 7, 1999, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 7, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Isosorbide Mononitrate60MG ยท tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
| Mar 21, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Oct 7, 1999 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters